{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:21:31Z","timestamp":1790029291532,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007293","name":"Obesity Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007293","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Pillars"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.obpill.2026.100254","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:26:50Z","timestamp":1772702810000},"page":"100254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Joint TOS\/OMA\/OAC expert guidance statement on the pharmacological management of United States adults with overweight or obesity using the GRADE approach"],"prefix":"10.1016","volume":"18","author":[{"given":"Lydia","family":"Alexander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Q.","family":"Purnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlijn","family":"Burridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andr\u00e9","family":"Cornier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah Bade","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Look","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5521-9662","authenticated-orcid":false,"given":"Joe","family":"Nadglowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"\u00c1vila-Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Novillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Rojas-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0549-8314","authenticated-orcid":false,"given":"Ximena Ramos","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.obpill.2026.100254_bib1","series-title":"Obesity and severe obesity prevalence in adults: united States, August 2021\u2013 August 2023","author":"Emmerich","year":"2024"},{"key":"10.1016\/j.obpill.2026.100254_bib2","article-title":"Factors associated with receiving an obesity diagnosis and obesity-related treatment for patients with obesity class II and III within a single integrated health system","volume":"46","author":"Szymanski","year":"2024","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.obpill.2026.100254_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/MLR.0000000000002113","article-title":"Trends in obesity care among US adults, 2010-2021","volume":"63","author":"Podolsky","year":"2025","journal-title":"Med Care"},{"key":"10.1016\/j.obpill.2026.100254_bib4","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/oby.22173","article-title":"Prevalence and determinants of engagement with obesity care in the United States","volume":"26","author":"Stokes","year":"2018","journal-title":"Obesity"},{"key":"10.1016\/j.obpill.2026.100254_bib5","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000001221","article-title":"Implementation of obesity science into clinical practice: a scientific statement from the American heart association","volume":"150","author":"Laddu","year":"2024","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.obpill.2026.100254_bib6","first-page":"S102","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American college of cardiology\/American heart association task force on practice guidelines and the obesity society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.obpill.2026.100254_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an endocrine society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"S3","key":"10.1016\/j.obpill.2026.100254_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.obpill.2026.100254_bib9","unstructured":"International Committee of Medical Journal Editors, \u201cRecommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals,\u201d accessed September 18, 2025, https:\/\/www.icmje.org\/recommendations\/."},{"key":"10.1016\/j.obpill.2026.100254_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-053246","volume":"12","author":"Morgano","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.obpill.2026.100254_bib12","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Br Med J"},{"key":"10.1016\/j.obpill.2026.100254_bib13","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"Br Med J"},{"key":"10.1016\/j.obpill.2026.100254_bib14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.obpill.2026.100254_bib15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"Br Med J"},{"key":"10.1016\/j.obpill.2026.100254_bib16","article-title":"GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"Br Med J"},{"key":"10.1016\/j.obpill.2026.100254_bib17","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04088","article-title":"Incidence and temporal trends in type 2 diabetes by weight status: a systematic review and meta-analysis of prospective cohort studies","volume":"13","author":"Yu","year":"2023","journal-title":"J Glob Health"},{"key":"10.1016\/j.obpill.2026.100254_bib18","article-title":"Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies","volume":"376","author":"Jayedi","year":"2022","journal-title":"Br Med J"},{"key":"10.1016\/j.obpill.2026.100254_bib19","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/obr.12656","article-title":"Body mass index, abdominal adiposity, weight gain and risk of developing hypertension: a systematic review and dose-response meta-analysis of more than 2.3 million participants","volume":"19","author":"Jayedi","year":"2018","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2026.100254_bib20","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1186\/s12889-024-19358-0","article-title":"The association between the visceral to subcutaneous abdominal fat ratio and the risk of cardiovascular diseases: a systematic review","volume":"24","author":"Emamat","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.obpill.2026.100254_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103221","article-title":"The relationship between obesity and obstructive sleep apnea in four community-based cohorts: an individual participant data meta-analysis of 12,860 adults","volume":"83","author":"Esmaeili","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.obpill.2026.100254_bib22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.joca.2024.08.012","article-title":"Comparison of weight loss interventions in overweight and Obese adults with knee osteoarthritis: a systematic review and network meta-analysis of randomized trials","volume":"33","author":"Shahid","year":"2025","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.obpill.2026.100254_bib23","doi-asserted-by":"crossref","first-page":"8612","DOI":"10.1038\/s41598-024-73132-1","article-title":"Predicting hepatic steatosis degree in metabolic dysfunction-associated steatotic liver disease using obesity and lipid-related indices","volume":"15","author":"Forouzesh","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.obpill.2026.100254_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1584799","article-title":"Primary care patient and practice member perspectives on weight loss medications: challenges and opportunities","volume":"12","author":"Holtrop","year":"2025","journal-title":"Front Med"},{"key":"10.1016\/j.obpill.2026.100254_bib25","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/dom.14809","article-title":"Ease-OfUse and acceptability of the novel semaglutide 2.4 Mg single-dose pen-injector in people with overweight or obesity in the STEP 8 phase III trial","volume":"24","author":"Snitker","year":"2022","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.obpill.2026.100254_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/17512433.2022.2070473","article-title":"Pharmacological profile of once-weekly injectable semaglutide for chronic weight management","volume":"15","author":"Lau","year":"2022","journal-title":"Expet Rev Clin Pharmacol"},{"key":"10.1016\/j.obpill.2026.100254_bib27","article-title":"Advances in anti-obesity pharmacotherapy: current treatments, emerging therapies, and challenges","volume":"15","author":"Brandfon","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.obpill.2026.100254_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.5586","article-title":"Lifetime health effects and cost-effectiveness of tirzepatide and semaglutide in US adults","volume":"6","author":"Hwang","year":"2025","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.obpill.2026.100254_bib29","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/s41366-022-01176-2","article-title":"International lack of equity in modern obesity therapy: the critical need for change in health policy","volume":"46","author":"Roser","year":"2022","journal-title":"Int J Obes"},{"key":"10.1016\/j.obpill.2026.100254_bib30","doi-asserted-by":"crossref","DOI":"10.57264\/cer-2025-0083","article-title":"Affordable access to GLP-1 obesity medications: strategies to guide market action and policy solutions in the US","volume":"14","author":"Pearson","year":"2025","journal-title":"Journal of Comparative Effectiveness Research"},{"key":"10.1016\/j.obpill.2026.100254_bib31","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/dom.15473","article-title":"Association of patient characteristics and insurance type with anti-obesity medications prescribing and fills","volume":"26","author":"Gasoyan","year":"2024","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.obpill.2026.100254_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.3474","article-title":"Estimated sustainable cost-based prices for diabetes medicines","volume":"7","author":"Barber","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"20","key":"10.1016\/j.obpill.2026.100254_bib33","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1001\/jama.2025.15841","article-title":"Medicare part D coverage and costs for glucagon-like Peptide-1 receptor agonists","volume":"334","author":"Klebanoff","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.obpill.2026.100254_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103422","article-title":"Development of a core patient-centred outcome set for adults living with obesity: a modified delphi-based international consensus","volume":"87","author":"Mekonnen","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.obpill.2026.100254_bib36","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1007\/s11695-024-07381-4","article-title":"Core set of patient-reported outcome measures for measuring quality of life in clinical obesity care","volume":"34","author":"Dijkhorst","year":"2024","journal-title":"Obes Surg"},{"key":"10.1016\/j.obpill.2026.100254_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13849","article-title":"A core set of patient-reported outcome measures to measure quality of life in obesity treatment research","volume":"26","author":"Dijkhorst","year":"2025","journal-title":"Obes Rev"}],"container-title":["Obesity Pillars"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:09:35Z","timestamp":1780060175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667368126000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":35,"alternative-id":["S2667368126000100"],"URL":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100254","relation":{},"ISSN":["2667-3681"],"issn-type":[{"value":"2667-3681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Joint TOS\/OMA\/OAC expert guidance statement on the pharmacological management of United States adults with overweight or obesity using the GRADE approach","name":"articletitle","label":"Article Title"},{"value":"Obesity Pillars","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc on behalf of Obesity Medicine Association and by John Wiley and Sons Inc. on behalf of The Obesity Society.","name":"copyright","label":"Copyright"}],"article-number":"100254"}}